Cargando…
Inhibition and counterinhibition of Surfacen, a clinical lung surfactant of natural origin
Inactivation of pulmonary surfactant by different components such as serum, cholesterol or meconium contributes to severe respiratory pathologies through destabilization and collapse of airspaces. Recent studies have analyzed in detail how the interfacial properties of natural surfactant purified fr...
Autores principales: | Lugones, Yuliannis, Blanco, Odalys, López-Rodríguez, Elena, Echaide, Mercedes, Cruz, Antonio, Pérez-Gil, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147439/ https://www.ncbi.nlm.nih.gov/pubmed/30235278 http://dx.doi.org/10.1371/journal.pone.0204050 |
Ejemplares similares
-
In Vitro Functional and Structural Characterization of A Synthetic Clinical Pulmonary Surfactant with Enhanced Resistance to Inhibition
por: Echaide, Mercedes, et al.
Publicado: (2020) -
Pulmonary Surfactant and Drug Delivery: An Interface-Assisted Carrier to Deliver Surfactant Protein SP-D Into the Airways
por: García-Mouton, Cristina, et al.
Publicado: (2021) -
Controlled hypothermia may improve surfactant function in asphyxiated neonates with or without meconium aspiration syndrome
por: Autilio, Chiara, et al.
Publicado: (2018) -
SP-D attenuates LPS-induced formation of human neutrophil extracellular traps (NETs), protecting pulmonary surfactant inactivation by NETs
por: Arroyo, Raquel, et al.
Publicado: (2019) -
Metabolism of a synthetic compared with a natural therapeutic pulmonary surfactant in adult mice
por: Madsen, Jens, et al.
Publicado: (2018)